Is TEAR a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

280 people get TEAR articles and Market Currents by email alert.

Get email alerts on TEAR »

HEADLINES:

TearLab's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Mon, May 13 • 1 Comment
TearLab Corporation Reports Q1-13 Financial Results

GlobeNewswire (May 13, 2013)
Ophthalmology: A Niche Where Innovation Pays
Richard Richter • Mon, May 6 • 1 Comment
TearLab Corporation to Release Q1 2013 Financial Results on May 13, 2013

GlobeNewswire (Apr 29, 2013)
TearLab: Watch For A Sharp Drop On Equity Offering
Richard Pearson • Wed, Apr 24 • 11 Comments
TearLab Launches Free Smartphone Investor Relations App

GlobeNewswire (Apr 9, 2013)
TearLab's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Mar 20
TearLab Corporation Reports 2012 Financial Results

GlobeNewswire (Mar 20, 2013)
Can TearLab Stay On A Tear?
Stephen Simpson • Thu, Mar 14 • 1 Comment
TearLab to Present at the 25th Annual ROTH Conference

GlobeNewswire (Mar 11, 2013)
Medical Device Industry: Outlook Of The Biomedical Sector In U.S.
StockRiters • Thu, Mar 7 • 2 Comments
TearLab Corporation to Release Q3 and Full Year 2012 Financial Results on March 20, 2013

GlobeNewswire (Feb 21, 2013)
TearLab to Present at the 24th Annual Piper Jaffray Healthcare Conference

GlobeNewswire (Nov 15, 2012)
TearLab Corporation Reports Q3-12 Financial Results

GlobeNewswire (Nov 13, 2012)
TearLab Corporation to Release Q3 2012 Financial Results on November 13, 2012

GlobeNewswire (Oct 30, 2012)
TearLab to Participate in Craig-Hallum's 3rd Annual Alpha Select Conference

GlobeNewswire (Sep 20, 2012)
TearLab Corporation Reports Q2-12 Financial Results

GlobeNewswire (Aug 8, 2012)
TearLab Corporation to Release Q2 2012 Financial Results on August 8, 2012

GlobeNewswire (Jul 24, 2012)
TearLab Corporation Announces the Pricing of a Registered Financing

GlobeNewswire (Jul 12, 2012)
TearLab to Participate in the 9th Annual Craig-Hallum Institutional Investor Conference

GlobeNewswire (May 24, 2012)

Can TearLab Stay On A Tear?
Stephen Simpson • Thu, Mar 14 • 1 Comment

TearLab: Watch For A Sharp Drop On Equity Offering
Richard Pearson • Wed, Apr 24 • 11 Comments
Can TearLab Stay On A Tear?
Stephen Simpson • Thu, Mar 14 • 1 Comment

Ophthalmology: A Niche Where Innovation Pays
Richard Richter • Mon, May 6 • 1 Comment
Medical Device Industry: Outlook Of The Biomedical Sector In U.S.
StockRiters • Thu, Mar 7 • 2 Comments
A Talk With Roth Capital Medical Technology Analyst Matt Dolan
Len Zehr • Thu, Feb 23, 2012
Top Q3 Picks Of Biotech-Focused Hedge Fund DAFNA Capital
GuruFundPicks • Fri, Nov 18, 2011
Insider Buying: 5 Recent CEO Buys of at Least $100K
The Keating Letter • Fri, Jul 8, 2011 • 12 Comments

TearLab's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Mon, May 13 • 1 Comment
TearLab's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Mar 20

TearLab Corporation Reports Q1-13 Financial Results

GlobeNewswire (May 13, 2013)
TearLab Corporation to Release Q1 2013 Financial Results on May 13, 2013

GlobeNewswire (Apr 29, 2013)
TearLab Launches Free Smartphone Investor Relations App

GlobeNewswire (Apr 9, 2013)
TearLab Corporation Reports 2012 Financial Results

GlobeNewswire (Mar 20, 2013)
TearLab to Present at the 25th Annual ROTH Conference

GlobeNewswire (Mar 11, 2013)
TearLab Corporation to Release Q3 and Full Year 2012 Financial Results on March 20, 2013

GlobeNewswire (Feb 21, 2013)
TearLab to Present at the 24th Annual Piper Jaffray Healthcare Conference

GlobeNewswire (Nov 15, 2012)
TearLab Corporation Reports Q3-12 Financial Results

GlobeNewswire (Nov 13, 2012)
TearLab Corporation to Release Q3 2012 Financial Results on November 13, 2012

GlobeNewswire (Oct 30, 2012)
TearLab to Participate in Craig-Hallum's 3rd Annual Alpha Select Conference

GlobeNewswire (Sep 20, 2012)
TearLab Corporation Reports Q2-12 Financial Results

GlobeNewswire (Aug 8, 2012)
TearLab Corporation to Release Q2 2012 Financial Results on August 8, 2012

GlobeNewswire (Jul 24, 2012)
TearLab Corporation Announces the Pricing of a Registered Financing

GlobeNewswire (Jul 12, 2012)
TearLab to Participate in the 9th Annual Craig-Hallum Institutional Investor Conference

GlobeNewswire (May 24, 2012)
TearLab Corporation Reports Q1-12 Financial Results

GlobeNewswire (May 14, 2012)
TearLab Corporation to Release Q1 2012 Financial Results on May 14, 2012

GlobeNewswire (May 3, 2012)
Study on Potential Impact of Pre-Operative Osmolarity on LASIK Outcomes to be Presented at ARVO 2012

GlobeNewswire (May 1, 2012)
Groundbreaking Osmolarity Prevalence Study Presented at ASCRS 2012

GlobeNewswire (Apr 23, 2012)
TearLab Corporation Announces Closing of Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

GlobeNewswire (Apr 16, 2012)
TearLab Corporation Prices $10.8 Million Public Offering of Common Stock

GlobeNewswire (Apr 11, 2012)

TEAR vs. ETF Alternatives

Company Description

Currently, there's no company description for TEAR.

Sector: Healthcare

Industry: Medical Laboratories & Research

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 14, 12:45 PM Midday top 10 gainers: PDII +31%. UNTK +22%. ALIM +19%. SODA +15%. CHLN +15%. TEAR +14%. ESI +14%. ECTY +14%. BVSN +12%. RVLT 12%.
Midday top 10 losers: TELOZ -28%. OPXA -19%. SED -16%. STXS -14%. FMAR -13%. VELT -12%. TSRE -12%. TRMD -11%. CCCL -10%. PT -10%. Comment! [On the Move]
Tuesday, May 14, 10:23 AM TearLab (TEAR +10.6%) ramps higher this morning after reporting Q1 sales that topped the Street's $2.19M estimate. Net revenues soared 486% from the same period last year, and an increase of 54% sequentially from the previous quarter. A total of 388 orders for its TearLab Osmolarity systems were booked in Q1. Net losses for the quarter were $9.1M, including approximately $6.6M in non-cash expense related to the revaluation of warrants issued in June 2011. As of March 31, the company had $12.3M remaining in cash. Comment! [Healthcare, Earnings, On the Move]
Monday, May 13, 4:33 PM TearLab (TEAR): Q1 EPS of -$0.30 misses by $0.18. Revenue of $2.48M beats by $0.3M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, April 24, 10:24 AM TearLab (TEAR -2%) "will clearly need to issue a sizable amount of equity at a price of $6 or below," writes SA contributor Richard Pearson who goes on to call the company "a serial dilution machine" and questions the size of the market for the TEAR's products. Pearson's commentary refutes bullish analysis from what he calls "small, retail-oriented brokerages." TEAR's shares are up ~160% since last June and the company beat on the top line each of the last two quarters (I, II). Comment! [Healthcare]
Wednesday, March 20, 7:36 AM TearLab (TEAR): Q4 EPS of -$0.13 misses by $0.03. Revenue of $1.61M beats by $0.02M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, November 13, 2012, 7:38 AM TearLab (TEAR): Q3 EPS of -$0.17 misses by $0.06. Revenue of $1.21M (+264% Y/Y) beats by $0.2M. (PR) Comment! [Earnings, Healthcare]
Wednesday, August 29, 2012, 9:16 AM TearLab (TEAR) +6.2% premarket after Canaccord Genuity initiates coverage with a Buy rating a $6 price target, noting the company offers the first point of care instrument that can quantitatively measure and diagnose dry eye disease. The firm says U.S. market potential includes 50,000 eye specialists who see on average six dry eye patients per day, equaling a $1.8B opportunity. Comment! [Healthcare, Quick Ideas, On the Move]
Wednesday, August 29, 2012, 9:10 AM Premarket gainers: JOSB +14%. TEAR +8%. MCP +6%. TFM +5%.
Losers: ARQL -26%. WCRX -22%. DY -17%. JASO -9%. FRO -8%. Comment! [On the Move]
Tuesday, April 10, 2012, 7:10 PM TearLab (TEAR) trades lower in the post-session after announcing a secondary offering to sell an undisclosed number of shares of common stock. Proceeds from the offering will be used for working capital and general corporate purposes. Shares -5% AH. Comment! [Tech]

TEAR TearLab Corporation

TEAR

TearLab Corporation